Synergy Between PCI With TAXUS and Cardiac Surgery: SYNTAX Extended Survival

Synergy Between PCI With TAXUS and Cardiac Surgery: SYNTAX Extended Survival

An investigator-driven, retrospective study to compare long-term survival-data (10-year follow-up) of patients with coronary artery disease (CAD), previously enrolled in the SYNTAX trial, who were randomized to percutaneous coronary intervention (PCI) using a paclitaxel (TAXUS) drug-eluting-stent (DES) or coronary artery bypass grafting (CABG).

Patients which have previously been enrolled in the SYNTAX trial (randomized and registry patients)